Dolutegravir for second-line antiretroviral therapy: the beat goes on

Authors: Nosipho Shangase, Tendesayi Kufa

Published: 2023-12-21

DOI: 10.1016/s2214-109x(23)00569-7

Source: Full article

Abstract

No abstract found.